Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 22, 2018, after the close
10-K filed Mar 22, 2018, 81 days after period end · 0000320017-18-000021
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | — | $10.18M | $7.56K | $5.28K |
| Net Income | -$2.14M | -$5.44M | -$33.20K |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$11.61K |
| EPS Diluted | — | — | -$0.59 | -$0.32 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
